4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065774
SVP and General Counsel sold 6,530 shares at an average $57.86 ($377,797)
- SVP and General Counsel acquired 6,530 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2020-12-31 | Option exercise | +4,759 | $7.80 | $37,120 | 6,059 | D: show line 1 in the form |
| Taylor Stacy L SVP and General Counsel | 2020-12-31 | Option exercise | +1,771 | $6.55 | $11,600 | 7,830 | D: show line 2 in the form |
| Taylor Stacy L SVP and General Counsel | 2020-12-31 | Sale | −4,529 | $57.54 | $260,599 | 3,301 | D: show line 3 in the form |
| Taylor Stacy L SVP and General Counsel | 2020-12-31 | Sale | −1,610 | $58.40 | $94,024 | 1,691 | D: show line 4 in the form |
| Taylor Stacy L SVP and General Counsel | 2020-12-31 | Sale | −391 | $59.27 | $23,175 | 1,300 | D: show line 5 in the form |
| Open-market sales · 6,530 sh · avg $57.86 · $377,797 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2020-12-31 | Option exercise · Stock Option (Right to Buy) | −4,759 | 29,167 | D: show line 6 in the form | ||
| Taylor Stacy L SVP and General Counsel | 2020-12-31 | Option exercise · Stock Option (Right to Buy) | −1,771 | 26,563 | D: show line 7 in the form |
Loading xslF345X03/doc4.xml…